N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT(1A) receptor binding site inactivation and turnover

Brain Research Protocols

Volumn 1, Issue 4, 1997, Pages 364-370

  Keck, B Jane ^a   Lakoski, Joan M ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Aging; N Ethoxycarbonyl 2 ethoxy 1,2 dihydroquinoline; Receptor inactivation; Receptor turnover; Serotonin; Serotonin 5 HT(1A) receptor

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; ALKYLATING AGENT; AMPHETAMINE DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROTOXIN; RECEPTOR SUBTYPE; SEROTONIN 1A RECEPTOR; SEROTONIN CREATININE SULFATE; TRYPTAMINE DERIVATIVE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; FEMALE; HIPPOCAMPUS; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE SPECIFICITY;

AGING; ANIMALS; BINDING SITES; BRAIN; MALE; MODELS, BIOLOGICAL; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0031251795     PISSN: 1385299X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1385-299X(97)00012-3     Document Type: Article

References (27)

1. 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), Eur. J. Pharmacol. 116 (1985) 175-178.
2. [2] B. Arranz, A. Eriksson, E. Mellerup, P. Plenge, J. Marcusson, Effect of aging in human cortical pre- and postsynaptic serotonin binding sites, Brain Res. 620 (1993) 163-166.
3. 2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment, J. Pharmacol. Exp. Ther. 243 (1987) 69-75.
4. [4] D. Bhaskaran, E. Radha, Monoamine levels and monoamine oxidase activity in different regions of rat brain as a function of age, Mech. Aging Dev. 23 (1983) 151-160.
5. [5] D.S. Charney, S.W. Woods, J.H. Krystal, G.R. Heninger, Serotonin function and human anxiety disorders, Ann. NY Acad. Sci. 600 (1990) 558-573.
6. 1A agonists, Synapse 14 (1993) 297-304.
7. [7] P.N. Devreotes, D.M. Fambrough, Acetylcholine receptor turnover in membranes of developing muscle fibers, J. Cell Biol. 65 (1975) 335-358.
8. [8] R.W. Fuller, New developments in serotonin pharmacology, in: R.R. Ruffolo Jr., M.A. Hollinger (Eds.), G-Protein Coupled Transmembrane Signaling Mechanisms, CRC Press, Boca Raton, FL, 1995, pp. 57-93.
9. [9] H. Gozlan, G. Daval, D. Verge, U. Spampinato, C.M. Fattaccini, M.C. Gallissot, S. El Mestikawy, M. Hamon, Aging associated changes in serotonergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain, Neurobiol. Aging 11 (1990) 437-449.
10. [10] H. Gozlan, A.-M. Laporte, S. Thibault, L.E. Schechter, F. Bolaños, M. Hamon, Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain, Neuropharmacology 33 (1994) 423-431.
11. 3H-PAT, Nature 305 (1983) 140-142.
12. 3H]S-HT binding in the CNS of female Fischer 344 rats, Neurosci. Lett. 101 (1989) 293-298.
13. [13] J.M. Henry, G.S. Roth, Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) blockade, Life Sci. 35 (1984) 899-904.
14. 1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), Brain Res. 728 (1996) 130-134.
15. 1A receptor turnover following irreversible blockade with EEDQ, NeuroReport 7 (1996) 2717-2721.
16. [16] J.M. Lakoski, B.J. Keck, A. Dugar, Neurochemical lesions: tools for functional assessment of serotonin neuronal systems, in: J.R. Perez-Polo (Ed.), Paradigms of Neural Injury. Methods in Neuroscience, Vol. 30, Academic Press, San Diego, CA, 1996, pp. 115-123.
17. 1 adrenergic receptors in a nonfusing muscle cell line, J. Biol. Chem. 257 (1982) 875-879.
18. [18] H.Y. Meltzer, Role of serotonin in depression, Ann. NY Acad. Sci. 600 (1990) 486-499.
19. [19] D.N. Middlemiss, A.M. Palmer, N. Edel, D.M. Bowen, Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin in normal and Alzheimer brain, J. Neurochem. 46 (1986) 993-996.
20. [20] A.B. Norman, I. Creese, Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain, Mol. Pharmacol. 30 (1986) 96-103.
21. [21] W. Pinto, G. Battaglia, In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites, NeuroReport 5 (1993) 61-64.
22. [22] W. Pinto, G. Battaglia, Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation, Mol. Pharmacol. 46 (1994) 1111-1119.
23. 1A receptor in the rat brain: correlation with receptor binding, J. Neurosci. 12 (1992) 440-453.
24. sα, Biochemistry 32 (1993) 11064-11073.
25. [25] L. Robson, A.J. Gower, D.A. Kendall, C.A. Marsden, Age-related behavioral, neurochemical, and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats, Psychopharmacology (Berlin) 113 (1993) 274-281.
26. 1-adrenergic receptors in rat submaxillary glands, Mol. Pharmacol. 23 (1983) 282-288.
27. [27] H.W.M. Steinbusch, M.G.P.A. Van Luijtelaar, H. Dijkstra, A. Nijssen, J.A.D.M. Tonnaer, Aging and regenerative capacity of the rat serotonergic system: a morphological, neurochemical and behavioral analysis after transplantation of fetal raphe cells, Ann. NY Acad. Sci. 600 (1990) 385-402.